Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Wanbangde Pharmaceutical Holding Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.04 Million ≈ $-151.51K USD) by net assets (CN¥2.77 Billion ≈ $404.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)

Cash flow conversion efficiency of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025. This chart illustrates how Wanbangde Pharmaceutical Holding Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Wanbangde Pharmaceutical Holding Group C stock quote for real-time trading data and today's change.

Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow Conversion Ratio Explained

Wanbangde Pharmaceutical Holding Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Wanbangde Pharmaceutical Holding Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wanbangde Pharmaceutical Holding Group Co Ltd ranked by their cash flow conversion efficiency. Also see 002082 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Fluence Energy Inc NASDAQ:FLNC	-0.040x
Capital City Bank Group NASDAQ:CCBG	0.022x
XiAn ChenXi Aviation Technology Corp Ltd SHE:300581	-0.005x
Karnov Group AB ST:KAR	0.108x
Scholastic Corporation NASDAQ:SCHL	0.079x
Jiangxi Huangshanghuang Group Food Co Ltd SHE:002695	0.026x
Hunan New Wellful Co Ltd SHG:600975	0.064x
Fujian Acetron New Materials Co Ltd SHE:300706	-0.038x

Annual Cash Flow Conversion Efficiency for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025. Review Wanbangde Pharmaceutical Holding Group C free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.61 Billion ≈ $381.57 Million	CN¥603.98 Million ≈ $88.38 Million	0.232x	+431.07%
2024-12-31	CN¥2.76 Billion ≈ $403.35 Million	CN¥120.22 Million ≈ $17.59 Million	0.044x	+265.13%
2023-12-31	CN¥2.76 Billion ≈ $403.72 Million	CN¥-72.87 Million ≈ $-10.66 Million	-0.026x	+68.93%
2022-12-31	CN¥2.82 Billion ≈ $412.52 Million	CN¥-239.65 Million ≈ $-35.07 Million	-0.085x	-1156.46%
2021-12-31	CN¥2.74 Billion ≈ $401.63 Million	CN¥22.09 Million ≈ $3.23 Million	0.008x	-84.77%
2020-12-31	CN¥2.86 Billion ≈ $418.23 Million	CN¥151.01 Million ≈ $22.10 Million	0.053x	+140.62%
2019-12-31	CN¥1.91 Billion ≈ $279.76 Million	CN¥-248.69 Million ≈ $-36.39 Million	-0.130x	-265.60%
2018-12-31	CN¥1.72 Billion ≈ $252.22 Million	CN¥135.40 Million ≈ $19.81 Million	0.079x	+815.48%
2017-12-31	CN¥1.60 Billion ≈ $234.64 Million	CN¥-17.60 Million ≈ $-2.58 Million	-0.011x	-104.93%
2016-12-31	CN¥1.40 Billion ≈ $204.36 Million	CN¥310.71 Million ≈ $45.47 Million	0.222x	+1687.76%
2015-12-31	CN¥1.35 Billion ≈ $197.11 Million	CN¥16.76 Million ≈ $2.45 Million	0.012x	-88.50%
2014-12-31	CN¥1.30 Billion ≈ $189.69 Million	CN¥140.31 Million ≈ $20.53 Million	0.108x	-45.14%
2013-12-31	CN¥1.19 Billion ≈ $173.83 Million	CN¥234.35 Million ≈ $34.29 Million	0.197x	+6.79%
2012-12-31	CN¥1.10 Billion ≈ $160.59 Million	CN¥202.73 Million ≈ $29.67 Million	0.185x	+13651.98%
2011-12-31	CN¥1.05 Billion ≈ $154.24 Million	CN¥-1.44 Million ≈ $-210.26K	-0.001x	-100.79%
2010-12-31	CN¥936.13 Million ≈ $136.98 Million	CN¥162.26 Million ≈ $23.74 Million	0.173x	+106.47%
2009-12-31	CN¥811.59 Million ≈ $118.76 Million	CN¥68.13 Million ≈ $9.97 Million	0.084x	-76.37%
2008-12-31	CN¥712.31 Million ≈ $104.23 Million	CN¥253.06 Million ≈ $37.03 Million	0.355x	+1084.23%
2007-12-31	CN¥415.12 Million ≈ $60.74 Million	CN¥12.45 Million ≈ $1.82 Million	0.030x	+206.57%
2006-12-31	CN¥357.72 Million ≈ $52.35 Million	CN¥3.50 Million ≈ $512.24K	0.010x	-86.67%
2005-12-31	CN¥152.88 Million ≈ $22.37 Million	CN¥11.23 Million ≈ $1.64 Million	0.073x	-69.41%
2004-12-31	CN¥136.17 Million ≈ $19.93 Million	CN¥32.69 Million ≈ $4.78 Million	0.240x	-36.09%
2003-12-31	CN¥98.53 Million ≈ $14.42 Million	CN¥37.01 Million ≈ $5.42 Million	0.376x	--

About Wanbangde Pharmaceutical Holding Group Co Ltd

SHE:002082 China Drug Manufacturers - Specialty & Generic

Market Cap

$867.35 Million

CN¥5.93 Billion CNY

Market Cap Rank

#9228 Global

#2244 in China

Share Price

CN¥9.69

Change (1 day)

+0.83%

52-Week Range

CN¥8.94 - CN¥36.24

All Time High

CN¥36.24